Artiva Biotherapeutics, Inc. (ARTV)
3.14
+0.07
(+2.28%)
USD |
NASDAQ |
Dec 11, 16:00
3.09
-0.05
(-1.59%)
After-Hours: 20:00
Artiva Biotherapeutics EPS Diluted (Quarterly): -0.8794 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | -0.171 |
| Kezar Life Sciences, Inc. | -1.533 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| Disc Medicine, Inc. | -1.772 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.53M |
| Total Expenses (Quarterly) | 21.53M |
| Enterprise Value | -34.78M |
| Earnings Yield | -103.4% |
| Normalized Earnings Yield | -103.45 |